keyword
MENU ▼
Read by QxMD icon Read
search

CT-P13

keyword
https://www.readbyqxmd.com/read/28176515/biosimilars-in-inflammatory-bowel-disease
#1
Carla J Gargallo, Alberto Lue, Fernando Gomollón
The introduction of biologic therapies has revolutionized the treatment of inflammatory bowel disease (IBD) and has significantly improved the disease course and outcomes for many patients. Biologics are the main drivers of cost in many IBD units and biosimilars, although are not better than originators, are usually cheaper and thus can increase the availability of this type of therapy. Biosimilar are highly similar to innovator but, due to the complex structures of innovators and the variability inherent in the manufacturing process, they are no identical...
February 7, 2017: Minerva Medica
https://www.readbyqxmd.com/read/28175254/p661-comparable-clinical-efficacy-safety-and-immunogenicity-of-infliximab-biosimilar-ct-p13-after-transition-from-reference-infliximab-remicade%C3%A2-in-children-with-established-inflammatory-bowel-disease-a-multi-centre-prospective-observational-study
#2
M Sladek, A Vultaggio, S Ghione, F Nencini, A Matucci, S Pratesi, F Zanieri, P M Maggi, M Paci, K Ponanta-Gawron, K Kulig, A Wasilewska, P Lionetti
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175221/p665-unchanged-infliximab-serum-concentrations-after-switching-from-the-reference-infliximab-to-the-biosimilar-ct-p13-in-patients-with-quiescent-crohn-s-disease-a-prospective-study
#3
A Strik, W van de Vrie, Y van Megen, J Bloemsaat-Minekus, T Rispens, G D'Haens
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175213/p679-infliximab-biosimilar-ct-p13-in-inflammatory-bowel-disease-patients-that-require-intensification-treatment
#4
M Gompertz, I Alfaro, E Ricart, A Lόpez, J Panés, M Gallego, R Barastegui, A Giner, A Vara, M Masamunt, I Ordás
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175208/p633-antibodies-to-infliximab-in-patients-treated-with-either-the-reference-biologic-or-the-biosimilar-ct-p13-show-identical-reactivity-towards-biosimilars-ct-p13-and-sb2-in-inflammatory-bowel-disease
#5
G Fiorino, M B Ruiz-Agüello, A Maguregui, D Nagore, S Radice, D Gilardi, C Correale, M Allocca, F Furfaro, M Alfieri, A Martínez, S Danese
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175199/p675-infliximab-biosimilar-ct-p13-therapy-is-effective-in-maintaining-clinical-remission-in-crohn-s-disease-and-ulcerative-colitis-54-week-data
#6
T Molnár, K Farkas, M Rutka, T Ferenci, F Nagy, A Bálint, R Bor, A Milassin, A Fábián, Z Végh, Z Kürti, P L Lakatos, Z Szepes
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175187/p586-a-novel-approach-to-the-implementation-of-biosimilar-infliximab-ct-p13-for-the-treatment-of-ibd-utilising-therapeutic-drug-monitoring-the-edinburgh-experience
#7
N Plevris, A Deekae, G R Jones, T A Manship, C L Noble, J Satsangi, A G Shand, I D Arnott, C W Lees
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175166/p605-rapid-detection-of-anti-infliximab-antibodies-in-inflammatory-bowel-disease-patients-treated-with-the-reference-biologic-or-the-biosimilar-ct-p13-performance-comparison-with-elisa
#8
G Fiorino, A Ametzazurra, D Nagore, A M Hernández, N Torres, S Radice, D Gilardi, C Correale, M Allocca, F Furfaro, M Alfieri, J Pascual, X Recalde, A Martínez, S Danese
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175126/p503-rapid-point-of-care-monitoring-of-anti-infliximab-antibodies-in-patients-with-inflammatory-bowel-disease-treated-with-the-reference-infliximab-or-ct-p13-in-routine-clinical-practice
#9
A Ametzazurra, N Rivera, A M Hernández, M P Arreba, E Ruiz, J Ortíz, M D C Muñoz, N Torres, J Pascual, A Martínez, M J Allande, D Nagore
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175115/p475-switching-from-infliximab-originator-to-ct-p13-is-not-related-to-increased-immunogenicity-in-ibd-patients-a-prospective-case-control-study
#10
G Fiorino, S Radice, D Gilardi, C Correale, M Allocca, F Furfaro, M Alfieri, D Nagore, L Del Rio, J Pascual, A Martínez, S Danese
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172988/p545-clinical-outcomes-following-a-switch-from-remicade%C3%A2-to-the-biosimilar-ct-p13-in-inflammatory-bowel-disease-patients-in-clinical-remission-preliminary-results
#11
L N Guerrero Puente, E Iglesias Flores, J M Benítez Cantero, M J Cárdenas Aranzana, R Medina Medina, I Salgueiro Rodríguez, P Aguilar Melero, B Manzanares Martin, V García-Sánchez
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172986/p663-switching-from-remicade%C3%A2-to-biosimilar-ct-p13-in-inflammatory-bowel-disease-patients-one-year-follow-up-of-a-prospective-observational-cohort-study
#12
L Smits, A Grelack, J Drenth, D de Jong, R Boshuizen, A van Esch, L Derikx, F Hoentjen
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172881/p582-the-pharmacoeconomic-impact-of-biosimilar-infliximab-ct-p13-in-europe-from-january-2015-to-june-2016
#13
S Han, S Kim, J Kim, D-H Kwon, J-S Choi, S-R Yoon, S-H Yun, D-S Kim, J-H Bae, H-J Choi, H-Y Sung, S-W Yoon
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172879/p487-effectiveness-and-safety-of-ct-p13-under-routine-care-in-paediatric-patients-with-inflammatory-bowel-disease
#14
Y H Choe, H R Yang, J S Moon, E Ryoo, S Kim, J H Lee, H J Kim, J H Park, M J Kim, S J Lee, S Y Lee
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172829/p500-effectiveness-and-safety-in-crohn-s-disease-patients-who-were-treated-with-ct-p13
#15
Y H Choe, S-H Lee, D I Park, J H Lee, H J Kim, Y-H Kim, C H Choi, C S Eun, S J Lee, S Lee
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172568/p508-association-between-clinical-outcome-and-post-induction-ct-p13-trough-levels-at-week-14-in-patients-with-inflammatory-bowel-disease-preliminary-results-in-an-observational-multicentric-study
#16
A Elosua González, D Oyόn Lara, Ó Nantes Castillejo, M Ά Ogueta Fernández, P Gutiérrez Mendizábal, M C Muñoz Villafranca, L Gόmez Irwin, A I Muñagorri Santos, I Rodríguez Lago, C Rodríguez Gutiérrez
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172472/dop062-biosimilar-infliximab-ct-p13-is-not-inferior-to-originator-infliximab-explorative-ibd-subgroup-analyses-in-crohn-s-disease-and-ulcerative-colitis-from-the-nor-switch-trial
#17
K K Jørgensen, I C Olsen, G L Goll, M Lorentzen, N Bolstad, I P Berset, E A Haavardsholm, K E Lundin, C Mørk, T K Kvien, J Jahnsen
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172425/dop061-phase-iii-randomised-double-blind-controlled-trial-to-compare-biosimilar-infliximab-ct-p13-with-innovator-infliximab-in-patients-with-active-crohn-s-disease-early-efficacy-and-safety-results
#18
Y H Kim, B D Ye, M Pesegova, O Alexeeva, M Osipenko, A Lahat, A Dorofeyev, A Salamon, S Fishman, O Levchenko, J H Cheon, M L Scribano, R-B Mateescu, K M Lee, C S Eun, S J Lee, S Y Lee
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28164249/extrapolation-and-interchangeability-of-infliximab-and-adalimumab-in-inflammatory-bowel-disease
#19
REVIEW
Shannon Chang, Stephen Hanauer
Infliximab and adalimumab biosimilars have been approved by the FDA and European Medicines Agency and have already been introduced to the international market. Availability into the US market is imminent. Biosimilars are highly similar to the reference biologic product but should not be referred to as, nor equated with, generic medications as no two biosimilars can ever be identical. Regulatory pathways for biosimilar approval consider the totality of evidence for biosimilar approvals, but the preponderance of development relies on analytic and functional testing and allows extrapolation between indications to reduce the financial burden of completing comparative clinical trials for each indication...
February 6, 2017: Current Treatment Options in Gastroenterology
https://www.readbyqxmd.com/read/28147374/experience-with-biosimilar-infliximab-remsima%C3%A2-in-norway
#20
Jørgen Jahnsen, Kristin Kaasen Jørgensen
BACKGROUND: The first monoclonal antibody biosimilar to be used in clinical practice is the tumour necrosis factor-alpha inhibitor Remsima® (CT-P13). The drug is approved for all indications as the originator infliximab (Remicade®) although clinical efficacy has been demonstrated only in rheumatic diseases. Since the fall of 2013, Remsima® has been available in Norway and from January 2014, it has been the drug of choice when initiating biological treatment in biologics naïve patients with inflammatory bowel disease (IBD)...
2017: Digestive Diseases
keyword
keyword
97571
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"